Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT03328949

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03328949
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, Denmark, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03328949. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-18 (actual); primary completion 2019-03-26 (actual). Results posted on 2019-11-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)
Intervention (Device)
IVL Coronary Lithotripsy System
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03328949
Content hash
ac6d2c10f8e7fa8600a93ea4274bbf6a048a3dfed0adf8167d63203b518109eb